Effect of Antacids on the Survival of Patients With Metastatic Urothelial Carcinoma Treated With Pembrolizumab-Reference-Cited by-同舟云学术

Effect of Antacids on the Survival of Patients With Metastatic Urothelial Carcinoma Treated With Pembrolizumab

Published:2024-08 Issue:4 Volume:22 Page:102097
ISSN:1558-7673
Container-title:Clinical Genitourinary Cancer
language:en
Short-container-title:Clinical Genitourinary Cancer

Author:

Sekito Takanori^ORCID,Bekku Kensuke,Katayama Satoshi^ORCID,Watanabe Tomofumi,Tsuboi Ichiro,Yoshinaga Kasumi,Maruyama Yuki^ORCID,Yamanoi Tomoaki,Kawada Tatsushi,Tominaga Yusuke,Sadahira Takuya,Iwata Takehiro,Nishimura Shingo,Kusumi Norihiro,Edamura Kohei,Kobayashi Tomoko^ORCID,Kurose Kyohei,Ichikawa Takaharu,Miyaji Yoshiyuki,Wada Koichiro,Kobayashi Yasuyuki,Araki Motoo^ORCID

Publisher

Elsevier BV

Reference31 articles.

1. PD-1 and PD-L1 inhibitors as salvage therapy for urothelial carcinoma;Sonpavde;N Engl J Med,2017

2. Pembrolizumab as second-line therapy for advanced urothelial carcinoma;Bellmunt;N Engl J Med,2017

3. Effect of antacid use on immune checkpoint inhibitors in advanced solid cancer patients: a systematic review and meta-analysis;Deng;J Immunother,2023

4. Efficacy of chemotherapy and atezolizumab in patients with non-small-cell lung cancer receiving antibiotics and proton pump inhibitors: pooled post hoc analyses of the OAK and POPLAR trials;Chalabi;Ann Oncol,2020

5. Acid suppressants reduce the therapeutic effect of immune checkpoint inhibitors and increase the risk of acute kidney injury: a meta-analysis;Okamoto;Int J Clin Oncol,2023

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Proton pump inhibitors and cancer treatments: Emerging evidence against coadministration;Cancer Treatment Reviews;2024-09